Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Clinical trial NCT04033302 · RECRUITING

Trial details

NCT number: NCT04033302
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia T-cell Acute Lymphoblastic Lymphoma Acute Myeloid Leukemia NK Cell Lymphoma

Start date: 2026-06-01
Primary completion: 2029-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.